Vitrafy enters a partnership with Hoxworth Blood Center

• Vitrafy partners with Hoxworth Blood Center to expand cryopreservation ecosystem
• Hoxworth is the oldest blood center in the US, collecting ~1% of US blood units annually
• Partnership aims to address the crisis in red blood cell preservation
• Vitrafy expects broader engagement with industry and government stakeholders
• The partnership is not expected to generate immediate revenue

Vitrafy Life Sciences Ltd (ASX: VFY) has announced a partnership with Hoxworth Blood Center to expand its next-generation cryopreservation ecosystem solution into a broader industry-wide response to the looming crisis in red blood cell preservation. Hoxworth, founded in 1938, is one of the oldest and most respected blood centers in the United States, collecting approximately 1% of US blood units annually and serving over 31 hospitals. This partnership aims to address the end-of-life of legacy red blood cell cryopreservation technology, which threatens the ability to cryopreserve and store red blood cells for both military stockpiles and civilian rare blood programs. Vitrafy and Hoxworth will contribute resources and in-kind support toward delivering a solution to this emerging threat. The agreement is not expected to generate revenue for the Company.